Sulfated glycosaminoglycans as promising artificial extracellular matrix components to improve the regeneration of tissues

Current Medicinal Chemistry

Volumn 20, Issue 20, 2013, Pages 2501-2523

  Schnabelrauch, M ^a   Scharnweber, D ^b   Schiller, J ^c  

^a BIOMATERIALS DEPARTMENT   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Chondroitin sulfate; Dermatan sulfate; Extracellular matrix; Glycosaminoglycans; Hyaluronan; Matrix engineering; Tissue engineering

Indexed keywords

CHONDROITIN; DERMATAN SULFATE; GLYCOSAMINOGLYCAN POLYSULFATE; HYALURONIC ACID;

ARTICLE; CARBOHYDRATE ANALYSIS; CELL CULTURE; DRUG SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; IN VIVO STUDY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; REGULATORY MECHANISM; SULFATION; TISSUE REGENERATION;

ANIMALS; CONNECTIVE TISSUE; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; PROTEIN BINDING; PROTEINS; REGENERATION; STEREOISOMERISM; SULFATES; TISSUE ENGINEERING;

EID: 84877937872     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320200001     Document Type: Article

References (183)

1. Schiller J.; Fuchs B.; Arnhold J.; Arnold K. Contribution of reactive oxygen species to cartilage degradation in rheumatic diseases: molecular pathways diagnosis and potential therapeutic strategies. Curr. Med. Chem. 2003 10(20) 2123-2145. (Pubitemid 37139067)
2. Pradhan S.; Farach-Carson M.C. Mining the extracellular matrix for tissue engineering applications. Regen. Med. 2010 5(6) 961-970.
3. Robert L. Matrix biology: past present and future. Pathol. Biol. (Paris) 2001 49(4) 279-283. (Pubitemid 32494252)
4. Tolar J.; Blazar B.R.; Wagner J.E. Concise review: transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa. Stem Cells 2011 29(6) 900-966.
5. Salbach J.; Rachner T.D.; Rauner M.; Hempel U.; Anderegg U.; Franz S.; Simon J.C.; Hofbauer L.C. Regenerative potential of glycosaminoglycans for skin and bone. J. Mol. Med. 2012 90(6) 625-635.
6. van der Smissen A.; Hintze V.; Scharnweber D.; Moeller S.; Schnabelrauch M.; Majok A.; Simon J.C.; Anderegg U. Growth promoting substrates for human dermal fibroblasts provided by ar tificial extracellular matrices composed of collagen I and sulfated glycosaminoglycans. Biomaterials 2011 32(34) 8938-8946.
7. Frantz C.; Stewart K.M.; Weaver V.M. The extracellular matrix at a glance. J. Cell Sci. 2010 123(24) 4195-4200.
8. Lieleg O.; Ribbeck K. Biological hydrogels as selective diffusion barriers. Trends Cell. Biol. 2011 21(9) 543-551.
9. Huster D. Solid-state NMR studies of collagen structure and dynamics in isolated fibrils and in biological tissues. Annu. Rep. NMR Spectrosc. 2008 64 127-159.
10. Pan J.; Qian Y.; Zhou X.; Lu H.; Ramacciotti E.; Zhang L. Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways. J. Biol. Chem. 2010 285(30) 22966-22975.
11. Gama C.I.; Hsieh-Wilson L.C. Chemical approaches to deciphering the glycosaminoglycan code. Curr. Opin. Chem. Biol. 2005 9(6) 609-619. (Pubitemid 41612188)
12. Merceron C.; Portron S.; Vignes-Colombeix C.; Rederstorff E.; Masson M.; Lesoeur J.; Sourice S.; Sinquin C.; Colliec-Jouault S.; Weiss P.; Vinatier C.; Guicheux J. Pharmacological modulation of human mesenchymal stem cell chondrogenesis by a chemically oversulfated polysaccharide of marine origin: potential application to cartilage regenerative medicine. Stem Cells 2012 30(3) 471-480.
13. Schlorke D.; Thomas L.; Samsonov S.A.; Huster D.; Arnhold J.; Pichert A. The influence of glycosaminoglycans on IL-8-mediated functions of neutrophils. Carbohydr. Res. 2012 356 196-203.
14. Nikitovic D.; Chatzinikolaou G.; Tsiaoussis J.; Tsatsakis A.; Karamanos N.K.; Tzanakakis G.N. Insights into targeting colon cancer cell fate at the level of proteoglycans / glycosaminoglycans. Curr. Med. Chem. 2012 19(25) 4247-4258.
15. Wei F.; Yan J.; Tang D. Extracellular signal-regulated kinases modulate DNA damage response -A contributing factor to using MEK inhibitors in cancer therapy. Curr. Med. Chem. 2011 18(35) 5476-5482.
16. Sasisekharan R.; Raman R.; Prabhakar V. Glycomics approach to structure-function relationships of glycosaminoglycans. Annu. Rev. Biomed. Eng. 2006 8 181-231. (Pubitemid 44314816)
17. Sugahara K.; Mikami T.; Uyama T.; Mizuguchi S.; Nomura K.; Kitagawa H. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr. Opin. Struct. Biol. 2003 13(5) 612-620. (Pubitemid 37244117)
18. Kogan G.; Soltés L.; Stern R.; Gemeiner P. Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol. Lett. 2007 29(1) 17-25. (Pubitemid 44950153)
19. Fraser J.R.; Laurent T.C.; Laurent U.B. Hyaluronan: its nature distribution functions and turnover. J. Intern. Med. 1997 242(1) 27-33. (Pubitemid 27323862)
20. Schiller J.; Fuchs B.; Arnold K. The molecular organization of polymers of cartilage: An overview of health and disease. Curr. Org. Chem. 2006 10(14) 1771-1789. (Pubitemid 44355993)
21. Funderburgh J.L. Keratan sulfate biosynthesis. IUBMB Life 2002 54(4) 187-194. (Pubitemid 36008327)
22. Gandhi N.S.; Mancera R.L. The structure of glycosamininoglycans and their interaction with proteins. Chem. Biol. Drug Des. 2008 72(6) 455-482.
23. Volpi N. Therapeutic applications of glycosaminoglycans. Curr. Med. Chem. 2006 13(15) 1799-1810. (Pubitemid 43871757)
24. Ramacciotti E.; Clark M.; Sadeghi N.; Hoppensteadt D.; Thethi I.; Gomes M.; Fareed J. Review: contaminants in heparin: review of the literature molecular profiling and clinical implications. Clin. Appl. Thromb. Hemost. 2011 17(2) 126-135.
25. Liu H.; Zhang Z.; Linhardt R.J. Lessons learned from the contamination of heparin. Nat. Prod. Rep. 2009 26(3) 313-321.
26. Alban S.; Lühn S.; Schiemann S.; Beyer T.; Norwig J.; Schilling C.; Rädler O.; Wolf B.; Matz M.; Baumann K.; Holzgrabe U. Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples. Anal. Bioanal. Chem. 2011 399(2) 605-620.
27. Schiller J. Volpi N. Hrabárová E. oltés L. Hyaluronic acid: A natural biopolymer. In: Biopolymers: Biomedical and Environmental Applications; Kalia Ed.; Scrivener 2011; 3-34.
28. Carney S.L.; Osborne D.J. The separation of chondroitin sulfate disaccharides and hyaluronan oligosaccharides by capillary zone electrophoresis. Anal. Biochem. 1991 195(1) 132-140.
29. Pichert A.; Schlorke D.; Franz S.; Arnhold J. Functional aspects of the interaction between interleukin-8 and sulfated gycosaminoglycans. Biomatter 2012 2(3) 142-148.
30. Karamanos N.K.; Syrokou A.; Vanky P.; Nurminen M.; Hjerpe A. Determination of 24 variously sulfated galactosaminoglycanand hyaluronan-derived disaccharides by high-performance liquid chromatography. Anal. Biochem. 1994 221(1) 189-199.
31. Sasisekharan R.; Shriver Z.; Venkataraman G.; Narayanasami. U. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer 2002 2(7) 521-528. (Pubitemid 37328933)
32. Hascall V.; Esko J.D. In: Essentials of Glycobiology; Varki A.; Cummings R.D.; Esko J.D.; Freeze H.H.; Stanley P.; Bertozzi C.R.; Hart G.W.; Etzler M.E. Eds.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor 2009 Chapter 15 219-227.
33. Calabro A.; Midura R.J.; Hascall V.C.; Plaas A.; Goodstone N.J.; Roden L. In: Proteoglycans Structure Biology and molecular Interactions; Iozzo R.V. Ed.; Marcel Dekker Inc.: New York 2000; Chapter 2 5-26.
34. Lamari F.N.; Karamanos N.K. In: Advances in Pharmacology; Volpi N. Ed.; Academic Press: San Diego 2006 33-48.
35. Prabhakar V.; Sasisekharan R. In: Advances in Pharmacology; Volpi N. Ed.; Academic Press: San Diego 2006 70-115.
36. Mizumoto S.; Kitagawa H.; Sugahara K. In: Chemistry and Biology of Heparin and Heparan Sulfate; Garg H.G.; Linhardt R.J.; Hales C.A. Eds.: Elsevier Ltd.: Oxford 2005 203-243.
37. Häcker U. Nybakken K. Perrimon N. Heparan sulphate proteoglycans: the sweet side of development. Nature Rev. Mol. Cell Biol. 2005 6(7) 530-541. (Pubitemid 40943044)
38. Sugahara K; Kitagawa H. Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr. Opin. Struct. Biol. 2000 10(5) 518-527.
39. Funderburgh J.L. Keratan sulfate biosynthesis. IUBMB Life 2002 54(4) 187-194. (Pubitemid 36008327)
40. Funderburgh J.L. Keratan sulphate: structure biosynthesis and function. Glycobiology 2000 10(10) 951-958.
41. Bergström S.Über die Wirkungsgruppe des Heparins. Naturwissenschaften 1935 23(41) 706.
42. Karrer P.; Koenig H.; Usteri E. Zur Kenntnis blutgerinnungshemmender Polysaccharid-polyschwefelsaure-ester und ähnlicher Verbindungen. Helv. Chim. Acta 1943 26(5) 1296-1315.
43. Meyer K.H.; Piroue R.P.; Odier M.E. Les derives sulfates de I'acide chondroitine-suIfurique et leur action anticoagulante. Sur les polysaccharides amines IV. Helv. Chim. Acta 1952 35(2) 574-588.
44. Nagasawa K.; Inoue Y. Reaction between carbohydrates and sulfuric acid. (2). Depolymerization and sulfation of chondroitin sulfate by sulfuric acid. Chem. Pharm. Bull. 1971 19(12) 2617-2622.
45. Naggi A.; Torri G.; Casu B.; Pangrazzi J.; Abbadini M.; Zameita M.; Donati M.B. Lansen J.; Maffrand J.P. Supersulfated heparin fragments a new type of low-molecular weight heparin. Physico-chemical and pharmacological properties. Biochem. Pharmacol. 1987 36(12) 1895-1900. (Pubitemid 17100208)
46. Maroufi R.M.; Tapon-Bretaudiere J.; Mardiguian J.; Sternberg C.; Dautzenberg M.D.; Fischer A.M. Influence of the oversulfation method and the degree of sulfation on the anticoagulant properties of dermatan sulfate derivatives. Thromb. Res. 1990 59(4) 749-758. (Pubitemid 20335214)
47. Nagasawa K.; Uchiyama H.; Wajima N. Chemical sulfation of preparations of chondroitin 4 and 6-sulfate and dermatan sulfate. Preparation of chondroitin sulfate E-like materials from chondroitin4-sulfate. Carbohydr. Res. 1986 158(1) 183-190.
48. Nadkarni; V.D.; Toida T; Van Gorp C.L.; Schubert R.L.; Weiler J. M.; Hansen K.P.; Caldwell E.E.O.; Linhardt R.L. Preparation and biological activity of N-sulfonated chondroitin and dermatan sulfate derivatives. Carbohydr. Res. 1996 290(1) 87-96 (Pubitemid 26261218)
49. Crescenzi V.; Francescangeli A.; Renier D.; Bellini D. New cross-linked and sulfated derivatives of partially deacetylated hyaluronan: synthesis and preliminary characterization. Biopolymers 2002 64(2) 86-94. (Pubitemid 34712559)
50. Magnani A.; Lamponi S.; Rappuoli R.; Barbucci R. Sulphated hyaluronic acids: A chemical and biological characterisation. Polym. Int. 1998 46(3) 225-240. (Pubitemid 128494635)
51. Casu B.; Naggi A.; Torri G. Chemical derivatization as a strategy to study structure-sctivity relationships of glycosaminoglycans. Seminars Thromb. Hemostasis 2002 28(4) 335-342. (Pubitemid 34971920)
52. Hintze V.; Moeller S.; Schnabelrauch M.; Bierbaum S.; Viola M.; Worch H.; Scharnweber D. Modifications of hyaluronan influence the interaction with human bone morphogenetic protein-4 (hBMP-4). Biomacromolecules 2009 10(12) 3290-3297.
53. Schiller J.; Becher J.; Möller S.; Nimptsch K.; Riemer T.; Schnabelrauch M. Synthesis and characterization of chemically modified glycosaminoglycans of the extracellular matrix. Mini-Rev. Org. Chem. 2010 7(4) 290-299.
54. Magnani A.; Albanese A.; Lamponi S.; Barbucci R. Bloodinteraction performance of differently sulphated hyaluronic acids. Thromb. Res. 1996 81(3) 383-395. (Pubitemid 26103283)
55. Becher J.; Möller S.; Riemer T.; Schiller J.; Hintze V.; Bierbaum S.; Scharnweber D.; Worch H.; Schnabelrauch M. Sulfated glycosaminoglycan building blocks for the design of artificial extracellular matrices. ACS Symp. Ser. 2012 1107 315-328.
56. Ludwig-Baxter K. G; Zhengchun Liu Z.; Perlin A. S. Regioselectivity in the sulfation of dermatan sulfate and methyl 4,6-Obenzylidene-D-idopyranoside. Carbohydr. Res. 1991 214(2) 245-256.
57. Ofosu F.A.; Modi G.J.; Blajchman M.A.; Buchanan M.R.; Johnson E.A. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate. Biochem. J. 1987 248(3) 889-896. (Pubitemid 18012730)
58. Ogamo A.; Metori A. Uchiyama H.; Nagasawa K. Reactivity toward chemical sulfation of hydroxyl groups of heparin. Carbohydr. Res. 1989 193(1) 165-172.
59. Kovensky J.; Cirelli A.F. Chemical modification of glycosaminoglycans: selective 2-sulfation of D-glucuronic acid units in heparan sulfate. Carbohydr. Res. 1997 303(1) 119-122. (Pubitemid 27414535)
60. Barbucci R.; Leone G.; Chiumiento A.; Di Cocco M.E.; D'Orazio G.; Raffaella Gianferri R.; Delfini M. Low-And highresolution nuclear magnetic resonance (NMR) characterisation of hyaluronan-based native and sulfated hydrogels. Carbohydr. Res. 2006 341(11) 1848-1858. (Pubitemid 43866043)
61. Möller S.; Schmidtke M.; Weiss D.; Schiller J.; Pawlik K.; Wutzler P.; Schnabelrauch M. Synthesis and antiherpetic activity of carboxymethylated and sulfated hyaluronan derivatives. Carbohydr. Polym. 2012 90(1) 608-615.
62. Roy A.; Urner J. On the desulphation of carbohydrate sulphates. Carbohydr. Res. 1983 124(2) 338-343.
63. Jaseja M.; Rej R.N.; Sauriol F.; Perlin A.S. Novel regio-And stereoselective modifications of heparin in alkaline solution. Nuclear magnetic resonance spectroscopic evidence. Can. J. Chemistry 1989 67(9) 1449-1456. (Pubitemid 19248003)
64. Usov A.I. Adamyants K.S. Miroshnikova L.I. Shaposhnikova A.A. Kochetkov N.K. Solvolytic desulphation of sulphated carbohydrates. Carbohydr. Res. 1971 18 (2) 336-338.
65. Matsuo M.; Takano R.; Kamei-Hayashi K.; Hara S. A novel regioselective desulfation of polysaccharide sulfates: Specific 6-Odesulfation with N,O-bis(trimethylsilyl)acetamide. Carbohydr. Res. 1993 241(1) 209-215. (Pubitemid 23085632)
66. Fernandez C.; Hattan C.M.; Kerns R.J. Semi-synthetic heparin derivatives: chemical modifications of heparin beyond chain length sulfate substitution pattern and N-sulfo/N-Acetyl groups. Carbohydr. Res. 2006 341(10) 1253-1265. (Pubitemid 43795386)
67. Inohue Y.; Nagasawa K. Selective N-desulfation of heparin with dimethyl sulfoxide containing water or methanol. Carbohydr. Res. 1976 46(1) 87-95.
68. Holme K.R.; Liang W.; Yang Z.; Lapierre F.; Shaklee P.N.; Lam L. In: Nonanticoagulant Actions of Glycosaminoglycans; Harenberg J.; Casu B. Eds.; Plenum Press: New York 1996; 139-162.
69. Kariya Y.; Kyogashima M.; Suzuki K.; Isomura T.; Sakamoto T.; Horie K.; Ishihara M.; Takanoi R.; Kameii K.; Harai S. Preparation of completely 6-O-desulfated heparin and its ability to enhance activity of basic fibroblast growth factor. J. Biol. Chem. 2000 275(34) 25949-25958.
70. Toida T.; Suzuki A.; Nakajima K.; Chaidedgumjorn A.; Imanari T. Effect of 6-O-sulfonate hexosamine residue on anticoagulant activity of fully O-sulfonated glycosaminoglycans. Glycoconjugate J. 2000 17(6) 393-399. (Pubitemid 32205013)
71. Kantor T.G.; Schubert M. Method for the desulfation of chondroitin sulfate. J. Am. Chem. Soc. 1957 79(1) 152-153.
72. McCarthy M.M.U.; John R. Bakers J.R. Isolation and desulphation of keratan sulphates. Carbohydr. Res. 1979 69(1) 151-164.
73. Naggi A.; De Cristofano B.; Bisio A.; Torri G.; Casu B. Generation of anti-factor Xa active 3-O-sulfated glucosamine-rich sequences by controlled desulfation of oversulfated heparins. Carbohydr. Res. 2001 336(4) 283-290. (Pubitemid 33139761)
74. Becher J.; Möller S.; Weiss D.; Schiller J.; Schnabelrauch M. Synthesis of new regioselelctively sulfated hyaluronans for biomedical application. Macromol. Symp. 2010 296 446-452.
75. Prento P. Staining of macromolecules: possible mechanisms and examples. Biotech. Histochem. 2009 84(4) 139-158.
76. Whiteman P. The quantitative determination of glycosaminoglycans in urine with Alcian Blue 8GX. Biochem. J. 1973 131(2) 351-357.
77. Gold E.W. The quantitative spectrophotometric estimation of total sulfated glycosaminoglycan levels. Formation of soluble alcian blue complexes. Biochim. Biophys. Acta 1981 673(4) 408-415. (Pubitemid 11103741)
78. Gray G.; Claridge P.; Jenkinson L.; Green A. Quantitation of urinary glycosaminoglycans using dimethylene blue as a screening technique for the diagnosis of mucopolysaccharidoses: An evaluation. Ann. Clin. Biochem. 2007 44(Pt 4) 360-363. (Pubitemid 351724672)
79. Bitter T.; Muir H.M. A modified uronic acid carbazole reaction. Anal. Biochem. 1962 4(4) 330-334.
80. Frazier S.B.; Roodhouse K.A.; Hourcade D.E.; Zhang L. The quantification of glycosaminoglycans: A comparison of HPLC carbazole and alcian blue methods. Open Glycosci. 2008 1 31-39.
81. Stylianou M.; Triantaphyllidou I.E.; Vynios D.H. Advances in the analysis of chondroitin/dermatan sulfate. Adv. Pharmacol. 2006 53 141-166.
82. Bottaro D.P. The role of extracellular matrix heparan sulfate glycosaminoglycan in the activation of growth factor signaling pathways. Ann. N. Y. Acad. Sci. 2002 961 158. (Pubitemid 34721761)
83. Chmielewski A.J.; Stanley F.E.; Stalcup A.M. The use of SAXHPLC-CD as a heparin screening strategy. J. Chromatogr. B 2011 879(25) 2619-2623.
84. Huang Y.; Washio Y.; Hara M.; Toyoda H.; Koshiishi I.; Toida T.; Imanari T. Simultaneous determination of dermatan sulfate and oversulfated dermatan sulfate in plasma by high-performance liquid chromatography with postcolumn fluorescence derivatization. Anal. Biochem. 1996 240(2) 227-234. (Pubitemid 26304266)
85. Volpi N.; Schiller J.; Stern R.; Soltés L. Role metabolism chemical modifications and applications of hyaluronan. Curr. Med. Chem. 2009 16(14) 1718-1745.
86. Gribbon P.; Heng B.C.; Hardingham T.E. The analysis of intermolecular interactions in concentrated hyaluronan solutions suggest no evidence for chain-chain association. Biochem. J. 2000 350(1) 329-335.
87. Capila I.; Sasisekharan R. In: Chemistry and Biology of Hyaluronan; Garg H.G.; Hales C.A. Eds.; Elsevier: Amsterdam 2004; 21-40.
88. Volpi N.; Maccari F.; Linhardt R.J. Capillary electrophoresis of complex natural polysaccharides. Electrophoresis 2008 29(15) 3095-3106.
89. Volpi N.; Maccari F.; Suwan J.; Linhardt R.J. Electrophoresis for the analysis of heparin purity and quality. Electrophoresis 2012 33(11) 1531-1537.
90. Norwig J.; Beyer T.; Brinz D.; Holzgrabe U.; Diller M.; Manns D. Prediction of the oversulphated chondroitin sulphate contamination of unfractionated heparin by ATR-IR spectrophotometry. Pharmeur. Sci. Notes 2009 2009(1) 17-24.
91. Servaty R.; Schiller J.; Binder H.; Arnold K. IR studies of the hydration of hyaluronic acid and chondroitin sulfate. Int. J. Biol. Macromol. 2001 28(2) 121-127.
92. Rudd T.R.; Yates E.A.; Hricovíni M. Spectroscopic and theoretical approaches for the determination of heparin saccharide structure and the study of protein-glycosaminoglycan complexes in solution. Curr. Med. Chem. 2009 16(35) 4750-4766.
93. Schiller J.; Huster D.; Fuchs B: Naji L.; Kaufmann J.; Arnold K. Evaluation of cartilage composition and degradation by highresolution magic-Angle spinning nuclear magnetic resonance. Methods Mol. Med. 2004 101 267-285.
94. Hricovíni M. Structural aspects of carbohydrates and the relation with their biological properties. Curr. Med. Chem. 2004 11(19) 2565-2583. (Pubitemid 39255551)
95. Bociek S.M.; Darke A.H.; Welti D.; Rees D.A. The 13C NMR spectra of hyaluronate and chondroitin sulphates. Further evidence on an alkali-induced conformation change. Eur. J. Biochem. 1980 109(2) 447-456.
96. Naji L.; Kaufmann J.; Huster D.; Schiller J.; Arnold K. 13C NMR relaxation studies on cartilage and cartilage components. Carbohydr. Res. 2000 327(4) 439-446. (Pubitemid 30456334)
97. Schiller J.; Huster D. New methods to study the composition and structure of the extracellular matrix in natural and bioengineered tissues. Biomatter 2012 2(3) 1-71.
98. Hao C.; Ma X.; Fang S.; Liu Z.; Liu S.; Song S.; Liu J. Positive and negative-ion matrix-Assisted laser desorption/ionization mass spectrometry of saccharides. Rapid Commun. Mass Spectrom. 1998 12(7) 345-348. (Pubitemid 28178510)
99. Galanos C.; Lüderitz O.; Himmelspach K. The partial acid hydrolysis of polysaccharides: A new method for obtaining oligosaccharides in high yield. Eur. J. Biochem. 1969; 8(3) 332-336.
100. Nimptsch A.; Schibur S.; Schnabelrauch M.; Fuchs B.; Huster D.; Schiller J. Characterization of the quantitative relationship between signal-to-noise (S/N) ratio and sample amount on-target by MALDI-TOF MS: Determination of chondroitin sulfate subsequent to enzymatic digestion. Anal. Chim. Acta 2009 635(2) 175-182.
101. Sommers C.D.; Mans D.J.; Mecker L.C.; Keire D.A. Sensitive detection of oversulfated chondroitin sulfate in heparin sodium or crude heparin with a colorimetric microplate based assay. Anal. Chem. 2011 83(9) 3422-3430.
102. Leone G.; Consumi M.; Lamponi S.; Magnani A. New hyaluroran derivative with prolonged half-life for ophthalmogical formulation. Carbohydr. Polymers 2012 88(3) 799-808.
103. Schiller J.; Arnhold J.; Sonntag K.; Arnold K. NMR studies on human pathologically changed synovial fluids: role of hypochlorous acid. Magn. Reson. Med. 1996 35(6) 848-853. (Pubitemid 26172620)
104. Grootveld M.; Henderson E.B.; Farrell A.; Blake D.R.; Parkes H.G.; Haycock P. Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by protonn. m.r. spectroscopy. Biochem. J. 1991 273(2) 459-467.
105. Yamada S.; Yoshida K.; Sugiura M.; Sugahara K. One-And twodimensional 1H-NMR characterization of two series of sulfated disaccharides prepared from chondroitin sulfate and heparan sulfate/ heparin by bacterial eliminase digestion. J. Biochem. 1992 112(4) 440-447.
106. Beyer T.; Diehl B.; Randel G.; Humpfer E.; Schäfer H.; Spraul M.; Schollmayer C.; Holzgrabe U. Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy. J. Pharm. Biomed. Anal. 2008 48(1) 13-19.
107. Pichert A.; Samsonov S.A.; Theisgen S.; Thomas L.; Baumann L.; Schiller J.; Beck-Sickinger A.G.; Huster D.; Pisabarro M.T. Characterization of the interaction of interleukin-8 with hyaluronan chondroitin sulfate dermatan sulfate and their sulfated derivatives by spectroscopy and molecular modeling. Glycobiology 2012 22(1) 134-145.
108. Sapay N.; Cabannes E.; Petitou M.; Imberty A. Molecular modeling of the interaction between heparan sulfate and cellular growth factors: bringing pieces together. Glycobiology 2011 21(9) 1181-1193.
109. James T.L.; McDonald G.G. Measurement of the self-diffusion coefficient of each component in a complex system using pulsedgradient fourier transform NMR. J. Magn. Reson. 1973 11(1) 58-61.
110. Nauman J.V.; Campbell P.G.; Lanni F.; Anderson J.L. Diffusion of insulin-like growth factor-I and ribonuclease through fibrin gels. Biophys. J. 2007 92(12) 4444-4450. (Pubitemid 46910557)
111. Sisu E.; Flangea C.; Serb A.; Zamfir A.D. Modern developments in mass spectrometry of chondroitin and dermatan sulfate glycosaminoglycans. Amino Acids 2011 41 235-256.
112. Hillenkamp F.; Peter-Katalini J. MALDI MS -A Practical Guide to Instrumentation. Methods and Application 1st ed.; Wiley-VCH: Weinheim 2007.
113. Northen T.R.; Yanes O.; Northen M.T.; Marrinucci D.; Uritboonthai W.; Apon J.; Golledge S.L.; Nordström A.; Siuzdak G. Clathrate nanostructures for mass spectrometry. Nature 2007 449(7165) 1033-1036. (Pubitemid 350017585)
114. Schiller J.; Arnhold J.; Benard S.; Reichl S.; Arnold K. Cartilage degradation by hyaluronate lyase and chondroitin ABC lyase: A MALDI-TOF mass spectrometric study. Carbohydr. Res. 1999 318(1-4) 116-122. (Pubitemid 29421790)
115. Prabhakar V.; Capila I.; Sasisekharan R. The structural elucidation of glycosaminoglycans. Methods Mol. Biol. 2009 534 147-156.
116. Linhardt R.J.; Avci F.Y.; Toida T.; Kim Y.S.; Cygler M. CS lyases: structure activity and applications in analysis and the treatment of diseases. Adv. Pharmacol. 2006 53 187-215.
117. Sakai S.; Hirano K.; Toyoda H.; Linhardt R.J.; Toida T. Matrix assisted laser desorption ionization-time of flight mass spectrometry analysis of hyaluronan oligosaccharides. Anal. Chim. Acta 2007 593(2) 207-213. (Pubitemid 46817524)
118. Riemer T.; Nimptsch A.; Nimptsch K.; Schiller J. Determination of the glycosaminoglycan and collagen contents in tissue samples by high-resolution 1H NMR spectroscopy after DCl-induced hydrolysis. Biomacromolecules 2012 13(7) 2110-2117.
119. Harvey D.J. Analysis of carbohydrates and glycoconjugates by matrix-Assisted laser desorption/ionization mass spectrometry: An update for 2007-2008. Mass Spectrom. Rev. 2012 31(2) 183-311.
120. Laremore T.N.; Murugesan S.; Park T.J.; Avci F.Y.; Zagorevski D.V.; Linhardt R.J. Matrix-Assisted laser desorption/ionization mass spectrometric analysis of uncomplexed highly sulfated oligosaccharides using ionic liquid matrices. Anal. Chem. 2006 78(6) 1774-1779.
121. Laremore T.N.; Linhardt R.J. Improved matrix-Assisted laser desorption/ionization mass spectrometric detection of glycosaminoglycan disaccharides as cesium salts. Rapid Commun. Mass Spectrom. 2007 21(7) 1315-1320. (Pubitemid 46506587)
122. Schulz R.; Höhle S.; Zernia G.; Zscharnack M.; Schiller J.; Bader A.; Arnold K.; Huster D. Analysis of extracellular matrix production in artificial cartilage constructs by histology immunocytochemistry mass spectrometry and NMR spectroscopy. J. Nanosci. Nanotechnol. 2006 6(8) 2368-2381. (Pubitemid 44599061)
123. Zaia J.; Li X.Q.; Chan S.Y.; Costello C.E. Tandem mass spectrometric strategies for determination of sulfation positions and uronic acid epimerization in chondroitin sulfate oligosaccharides. J. Am. Soc. Mass Spectrom. 2003 14(11) 1270-1281. (Pubitemid 37330131)
124. Böhme J.; Anderegg U.; Nimptsch A.; Nimptsch K.; Hacker M.; Schulz-Siegmund M.; Huster D.; Schiller J. De novo biosynthesis of glycosaminoglycans in the extracellular matrix of skin studied by matrix-Assisted laser desorption/ionization mass spectrometry. Anal. Biochem. 2012 421(2) 791-793.
125. Tissot; B: Ceroni A.; Powell A.K.; Morris H.R.; Yates E.A.; Turnbull J.E.; Gallagher J.T.; Dell A.; Haslam S.M. Software tool for the structural determination of glycosaminoglycans by mass spectrometry. Anal. Chem. 2008 80(23) 9204-9212.
126. Yamada H.; Miyauchi S.; Hotta H.; Morita M.; Yoshihara Y.; Kikuchi T.; Fujikawa K. Levels of chondroitin sulfate isomers in synovial fluid of patients with hip osteoarthritis. J. Orthop. Sci. 1999 4(4) 250-254. (Pubitemid 29404008)
127. Nimptsch K.; Süss R.; Riemer T.; Nimptsch A.; Schnabelrauch M.; Schiller J. Differently complex oligosaccharides can be easily identified by matrix-Assisted laser desorption and ionization timeof-flight mass spectrometry directly from a standard thin-layer chromatography plate. J. Chromatogr. A 2010 1217(23) 3711-3715.
128. Fuchs B.; Sü R.; Nimptsch A.; Schiller J. Matrix-Assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS) directly combined with thin-layer chromatography (TLC) -A review of the current state. CHROMATOGRAPHIA 2009 69(Suppl 1) 95-105.
129. Zhang Z.; Xie J.; Zhang F.; Linhardt R.J. Thin-layer chromatography for the analysis of glycosaminoglycan oligosaccharides. Anal. Biochem. 2007 371(1) 118-120. (Pubitemid 47538480)
130. Tissot B.; Gasiunas N.; Powell A.K.; Ahmed Y.; Zhi Z.L.; Haslam S.M.; Morris H.R.; Turnbull J.E.; Gallagher J.T.; Dell A. Towards GAG glycomics: Analysis of highly sulfated heparins by MALDI-TOF mass spectrometry. Glycobiology 2007 17(9) 972-982. (Pubitemid 47423887)
131. Nimptsch K.; Sü R.; Schnabelrauch M.; Nimptsch A.; Schiller J. Positive ion MALDI-TOF mass spectra are more suitable than negative ion spectra to characterize sulphated glycosaminoglycans. Int. J. Mass Spectrom. 2012 310 72-76.
132. Jamison F.W.; Foster T.J.; Barker J.A.; Hills R.D.; Guvench O. Mechanism of binding site conformational switching in the CD44-hyaluronanprotein- carbohydrate binding interaction. J. Mol. Biol. 2011 406(4) 631-647.
133. Afratis N.; Gialeli C.; Nikitovic D.; Tsegenidis T.; Karousou E.; Theocharis A.D.; Pavão M.S.; Tzanakakis G.N.; Karamanos N.K. Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J. 2012; 279(7) 1177-1197.
134. Abe T.; Fukuhara T.; Wen X.; Ninomiya A.; Moriishi K.; Maehara Y.; Takeuchi O.; Kawai T.; Akira S.; Matsuura Y. CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating through an interaction with Toll-like receptor 2 and hyaluronan. J. Virol. 2012 86(11) 6159-6170.
135. Yang C.; Cao M.; Liu H.; He Y.; Xu J.; Du Y.; Liu Y.; Wang W.; Cui L.; Hu J.; Gao F. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J. Biol. Chem. 2012 287(51) 43094-43107.
136. Ito K.; Higai K.; Shinoda C.; Sakurai M.; Yanai K.; Azuma Y.; Matsumoto K. Unlike natural killer (NK) p30 natural cytotoxicity receptor NKp44 binds tomultimeric -2,3-NeuNAc-containing Nglycans. Biol. Pharm. Bull. 2012 35(4) 594-600.
137. Bierbaum S.; Scharnweber D. Artificial extracellular matrices to functionalize biomaterial surfaces. In: P. Ducheyne K.E. Healy D.W. Hutmacher D.W. Grainger C.J. Kirkpatrick (eds.) Comprehensive Biomaterials 2011 2: 127-53.
138. Mummery R.S.: Rider C.C. Characterization of the heparinbinding properties of IL-6. J. Immunol. 2000 165(10) 5671-5679.
139. Nerucci F.; Fioravanti A.; Cicero M.R.; Collodel G.; Marcolongo R. Effects of chondroitin sulfate and interleukin-1beta on human chondrocyte cultures exposed to pressurization: A biochemical and morphological study. Osteoarthritis Cartilage 2000 8(4) 279-287. (Pubitemid 30620190)
140. Takeuchi Y.; Watanabe S.; Ishii G.; Takeda S.; Nakayama K.; Fukumoto S.; Kaneta Y.; Inoue D.; Matsumoto T.; Harigaya K.; Fujita T. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J. Biol. Chem. 2002 277(50) 49011-49018. (Pubitemid 35470873)
141. Zanetta J.P.; Bindeus R.; Normand G.; Durier V.; Lagant P.; Maes E.; Vergoten G. Evidence for a lectin activity for human interleukin 3 and modeling of its carbohydrate recognition domain. J. Biol. Chem. 2002 277(41) 38764-38771. (Pubitemid 35154739)
142. Imberty A.; Lortat-Jacob H.; Perez S. Structural view of glycosaminoglycan-protein interactions. Carbohydr. Res. 2007 342(3-4) 430-439. (Pubitemid 46161422)
143. Coombe D.R. Biological implications of glycosaminoglycan interactions with haemopoietic cytokines. Immunol. Cell. Biol. 2008 86(7) 598-607.
144. Vlodavsky I.; Miao H.Q.; Medalion B.; Danagher P.; Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev. 1996 15(2) 177-186. (Pubitemid 26236115)
145. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 1998 67 609-652. (Pubitemid 28411140)
146. Ashikari-Hada S.; Habuchi H.; Kariya Y.; Itoh N.; Reddi A.H.; Kimata K. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J. Biol. Chem. 2004 279(13) 12346-12354. (Pubitemid 38445801)
147. Huntington J.A. Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. J. Thromb. Haemost. 2003 1(7) 1535-1549.
148. Blanquaert F.; Carpentier G.; Morvan F.; Caruelle J.P.; Barritault D.; Tardieu M. RGTA modulates the healing pattern of a defect in a monolayer of osteoblastic cells by acting on both proliferation and migration. J. Biomed. Mater. Res. A 2003 64(3) 525-532. (Pubitemid 37522493)
149. Herndon M.E.; Stipp C.S.; Lander A.D. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: Assessment of selectivity heterogeneity and the participation of core proteins in binding. Glycobiology 1999 9(2) 143-155. (Pubitemid 29082484)
150. Hintze V.; Miron A.; Moeller S.; Schnabelrauch M.; Wiesmann H.P.; Worch H.; Scharnweber D. Sulfated hyaluronan and chondroitin sulfate derivatives interact differently with human transforming growth factor-1 (TGF-1). Acta Biomater. 2012 8(6) 2144-2152.
151. de Paz J.L.; Seeberger P.H. Recent advances and future challenges in glycan microarray technology. Methods Mol. Biol. 2012 808 1-16.
152. Rogers C.J.; Hsieh-Wilson L.C. Microarray method for the rapid detection of glycosaminoglycan-protein interactions. Methods Mol. Biol. 2012 808 321-336.
153. Merceron C.; Portron S.; Vignes-Colombeix C.; Rederstorff E.; Masson M.; Lesoeur J.; Sourice S.; Sinquin C.; Colliec-Jouault S.; Weiss P.; Vinatier C.;
154. Fazekas K.; Janovics A.; Dome B.; Koska P.; Albini A.; Timar J. Effect of HGF-like basic hexapeptides on angiogenesis. Microvasc. Res. 2001 62(3) 440-444. (Pubitemid 33027929)
155. Krieger E.; Geretti E.; Brandner B.; Goger B.; Wells T.N.; Kungl A.J. A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations. Proteins 2004 54(4) 768-775. (Pubitemid 38298795)
156. Takada T.; Katagiri T.; Ifuku M.; Morimura N.; Kobayashi M.; Hasegawa K.; Ogamo A.; Kamijo R. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J. Biol. Chem. 2003 278(44) 43229-43235. (Pubitemid 37345942)
157. Blackhall F.H.; Merry C.L.; Lyon M.; Jayson G.C.; Folkman J.; Javaherian K.; Gallagher J.T. Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates. Biochem. J. 2003 375(1) 131-139. (Pubitemid 37255388)
158. Tapon-Bretaudiere J.; Chabut D.; Zierer M.; Matou S.; Helley D.; Bros A.; Mourao P.A.; Fischer A.M. A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis. Mol. Cancer Res. 2002 1(2) 96-102. (Pubitemid 36312970)
159. Coltrini D.; Rusnati M.; Zoppetti G.; Oreste P.; Isacchi A.; Caccia P.; Bergonzoni L. Presta M. Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies. Eur. J. Biochem. 1993 214(1) 51-58. (Pubitemid 23168517)
160. Freeman C.; Liu L.; Banwell M.G.; Brown K.J.; Bezos A.; Ferro V.; Parish C.R. Use of sulfated linked cyclitols as heparan sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins. J. Biol. Chem. 2005 280(10) 8842-8849. (Pubitemid 40409573)
161. Lortat-Jacob H. The molecular basis and functional implications of chemokine interactions with heparan sulphate. Curr. Opin. Struct. Biol. 2009 19(5) 543-548.
162. Kreuger J.; Salmivirta M.; Sturiale L.; Gimenez-Gallego G.; Lindahl U. Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J. Biol. Chem. 2001 276(33) 30744-30752.
163. Allen B.L.; Rapraeger A.C. Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J. Cell Biol. 2003 163(3) 637-648. (Pubitemid 37429875)
164. Kreuger J.; Spillmann D.; Li J.P.; Lindahl U. Interactions between heparan sulfate and proteins: the concept of specificity. J. Cell Biol. 2006 174(3) 323-327. (Pubitemid 44156762)
165. Mulloy B.; Forster M.J. Application of drug discovery software to the identification of heparin-binding sites on protein surfaces: A computational survey of the 4-helix cytokines. Mol. Sim. 2008 34(4) 481-489.
166. Coombe D.R. Biological implications of glycosaminoglycan interactions with haemopoietic cytokines. Immunol. Cell Biol. 2008 86(7) 598-607.
167. Ernst S.; Langer R.; Cooney C.L.; Sasisekharan R. Enzymatic degradation of glycosaminoglycans. Crit. Rev. Biochem. Mol. Biol. 1995 30(5) 387-444.
168. Maire M.; Chaubet F.; Mary P.; Blanchat C.; Meunier A.; Logeart-Avramoglou D. Bovine BMP osteoinductive potential enhanced by functionalized dextran-derived hydrogels. Biomaterials 2005 26(24) 5085-5092. (Pubitemid 40354241)
169. Théoleyre S.; Kwan Tat S.; Vusio P.; Blanchard F.; Gallagher J.; Richard-Blum S.; Fortun Y.; Padrines M.; Rédini F.; Heymann D. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor B ligand [RANKL) and RANK. Biochem. Biophys. Res. Commun. 2006 347(2) 460-467. (Pubitemid 44063559)
170. Guezennec J.; Pignet P.; Lijour Y.; Gentric E.; Ratiskol J.; Colliec-Jouault S. Sulfation and depolymerization of a bacterial exopolysaccharide of hydrothermal origin. Carbohydr. Polym. 1998 37(1) 19-24. (Pubitemid 128425424)
171. Miyazaki T.; Miyauchi S.; Tawada A.; Anada T.; Matsuzaka S.; Suzuki O. Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation. J. Cell. Physiol. 2008 217(3) 769-777.
172. Pothacharoen P.; Kodchakorn K.; Kongtawelert P. Characterization of chondroitinsulfate from deer tip antler and osteogenic properties. Glycoconj. J. 2011 28(7) 473-480.
173. Peschel D.; Zhang K.; Aggarwal N.; Brendler E.; Fischer S.; Groth T. Synthesis of novel derivatives and investigation of their mitogenic activity in the presence and absence of FGF2. Acta Biomater. 2010 6(6) 2116-2125.
174. Büttner M.; Möller S.; Keller M.; Huster D.; Schiller J.; Schnabelrauch M.; Dieter P.; Hempel U. Over-sulfated chondroitin sulfate derivatives induce osteogenic differentiation of human mensenchymal stromal cells independent of bone morphogenetic proetin-2 and transforming growth factor-1 signalling. J. Cell. Physiol. 2013 228(2) 330-340.
175. Hempel U.; Möller S.; Noack C.; Hintze V.; Scharnweber D.; Schnabelrauch M.; Dieter P. Sulfated hyaluronan/collagen Imatrices enhance osteogenic differentiation of human mesenchymal stromal cells in vitro even in the absence of dexamethasone. Acta Biomater. 2012 8(11) 4064-4072.
176. Hess R.; Jaeschke A.; Neubert H.; Hintze V.; Moeller S.; Schnabelrauch M.; Wiesmann H.P.; Hart D.A.; Scharnweber. D. Synergistic effect of defined artificial extracellular matrices and pulsed electric fields on osteogenic differentiation of human MSCs. Biomaterials 2012 33(35) 8975-8985.
177. Saalbach J.; Kliemt S.; Rauner M.; Rachner T.D.; Goettsch C.; Kalkhof S.; von Bergen M.; Möller S.; Schnabelrauch M.; Hintze V.; Scharnweber D.; Hofbauer L.C. Glycosaminoglycans modulate osteoclast functions and signaling pathways depending on their degree of sulfation. Biomaterials 2012 33(33) 8418-8429.
178. Franz S.; Rammelt S.; Scharnweber D.; Simon J.C. Immune responses to implants -A review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011 32(28) 6692-6709.
179. Stadlinger B.; Hintze V.; Bierbaum S.; Möller S.; Schulz M.C.; Maia R.; Heinemann S.; Scharnweber D.; Schnabelrauch M.; Eckelt U. Biological functionalization of dental implants with collagen and glycosaminoglycans -A comparative study. J. Biomed. Mater. Res. B Appl. Biomater. 2012 100B(2) 331-341.
180. Stadlinger B.; Pilling E.; Huhle M.; Mai R.; Bierbaum S.; Bernhardt R.; Scharnweber D.; Kuhlisch E.; Hempel U.; Eckelt U. Influence of extracellular matrix coatings on implant stability and osseointegration. J. Biomed. Mater. Res. B Appl. Biomater. 2007 83(1) 222-231. (Pubitemid 47463217)
181. Stadlinger B.; Pilling E.; Huhle M.; Khavkin E.; Bierbaum S.; Scharnweber D.; Kuhlisch E.; Eckelt U.; Mai R. Suitability of differently designed matrix-based implant surface coatings: An animal study on bone formation. J. Biomed. Mater. Res. B Appl. Biomater. 2008 87(2) 516-524.
182. Stadlinger B.; Pilling E.; Huhle M.; Mai R.; Bierbaum S.; Scharnweber D.; Kuhlisch E.; Loukota R.; Eckelt U. Evaluation of osseointegration of dental implants coated with collagen chondroitin sulphate and BMP-4: An animal study. Int. J. Oral. Maxillofac. Surg. 2008 37(1) 54-59. (Pubitemid 350216394)
183. Stadlinger B.; Bierbaum S.; Grimmer S.; Schulz M.C.; Kuhlisch E.; Scharnweber D.; Eckelt U.; Mai R. Increased bone formation around coated implants. J. Clin. Periodontol. 2009 36(8) 698-704.